The Latest Breaking News from PBMs

Wegovy and Ozempic are weight loss drugs that promise to transform the treatment of obesity, heart disease and other chronic conditions that afflict millions of Americans. But while everyone agrees these drugs have the potential to transform lives, no one can agree on how best to pay for them.

Kentucky’s attorney general has expanded an opioid-related lawsuit to target another pharmacy benefit manager

Lawmakers question whether the decision to renew Express Scripts as TRICARE's pharmacy benefit manager is a wise decision.

Biden is campaigning on cutting drug costs for Medicare patients, but independent pharmacists say one strategy makes it unaffordable to keep some brand-name medicines in stock.

Rural pharmacies can be a touchstone for their communities

Learn about the controversies surrounding US pharmacy benefit managers (PBMs) and the need for increased regulation and transparency in the healthcare system.

A seven-figure, yearlong PhRMA ad campaign has taken a very wonky policy debate mainstream — and it's made a longtime actor a familiar face.

A crackdown on pharmacy benefit managers on drug costs might help Congress forget their differences.

The Patients Before Middlemen Act strikes at the heart of what makes prescription drugs so unaffordable in the U.S., according to Howard Dean.